Overview
Jennifer Small-Saunders is an Infectious Disease provider in New York, New York. Dr. Small-Saunders is rated as an Advanced provider by MediFind in the treatment of Malaria. Her top area of expertise is Malaria.
Her clinical research consists of co-authoring 17 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 14 articles in the study of Malaria.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
622 W 168th St, New York, NY 10032
161 Fort Washington Ave, New York, NY 10032
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Yale University
Joseph Vinetz is an Infectious Disease provider in New Haven, Connecticut. Dr. Vinetz is rated as a Distinguished provider by MediFind in the treatment of Malaria. His top areas of expertise are Malaria, Leptospirosis, Sepsis, and Brucellosis.
Photini Sinnis is an Infectious Disease provider in New York, New York. Dr. Sinnis is rated as an Advanced provider by MediFind in the treatment of Malaria. Her top areas of expertise are Malaria, Primary Amebic Meningoencephalitis, and Toxoplasmosis.
Montefiore Weiler Hospital
Our primary research interest is in the biology, pathogenesis and immunology of Plasmodium falciparum. Patients infected with this parasite can be completely asymptomatic or develop severe disease resulting in death. The goal of our research has been to define the molecular mechanisms that underlie this variation in disease outcomes in P. falciparum. Toward this goal, we have developed a new pathogenesis model through the analysis of in vivo parasite biology and associated host factors using a whole genome and metabolomic approach. We have identified novel parasite biology when it resides in the human host and idnetified a putative mediator of coma in cerebral malaria. We also are studying adjunctive therapy to improve outcomes in severe malaria using the animal model. We carry out field based translational studies in cohorts infected with malaria in Africa and test hypothesis in the animal model of malaria. The long term goal is to identify parasite and host processes involved in disease to serve as targets for vaccine or chemotherapeutic development. Dr. Daily is rated as a Distinguished provider by MediFind in the treatment of Malaria. Her top areas of expertise are Primary Amebic Meningoencephalitis, Malaria, Togaviridae Disease, Severe Acute Respiratory Syndrome (SARS), and Leg or Foot Amputation.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers